April 1 - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated by Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab.
"Obviously, I assume you guys have a lot of questions. I just want to start by saying, I kind of expressed my statement on Saturday, and obviously would love to be able to give you more, but that's ...